• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

探索性别差异在唐氏综合征阿尔茨海默病发病机制中的作用。

Exploring the role of sex differences in Alzheimer's disease pathogenesis in Down syndrome.

作者信息

Andrews Elizabeth J, Martini Alessandra C, Head Elizabeth

机构信息

Department of Pathology and Laboratory Medicine, University of California, Irvine, Irvine, CA, United States.

Institute for Memory Impairments and Neurological Disorders, University of California, Irvine, Irvine, CA, United States.

出版信息

Front Neurosci. 2022 Aug 12;16:954999. doi: 10.3389/fnins.2022.954999. eCollection 2022.

DOI:10.3389/fnins.2022.954999
PMID:36033603
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9411995/
Abstract

Women are disproportionately affected by Alzheimer's disease (AD), yet little is known about sex-specific effects on the development of AD in the Down syndrome (DS) population. DS is caused by a full or partial triplication of chromosome 21, which harbors the amyloid precursor protein (APP) gene, among others. The majority of people with DS in their early- to mid-40s will accumulate sufficient amyloid-beta (Aβ) in their brains along with neurofibrillary tangles (NFT) for a neuropathological diagnosis of AD, and the triplication of the APP gene is regarded as the main cause. Studies addressing sex differences with age and impact on dementia in people with DS are inconsistent. However, women with DS experience earlier age of onset of menopause, marked by a drop in estrogen, than women without DS. This review focuses on key sex differences observed with age and AD in people with DS and a discussion of possible underlying mechanisms that could be driving or protecting from AD development in DS. Understanding how biological sex influences the brain will lead to development of dedicated therapeutics and interventions to improve the quality of life for people with DS and AD.

摘要

女性受阿尔茨海默病(AD)的影响尤为严重,但对于唐氏综合征(DS)人群中AD发展的性别特异性影响却知之甚少。DS是由21号染色体的全部或部分三体化引起的,该染色体除其他基因外还包含淀粉样前体蛋白(APP)基因。大多数40岁左右的DS患者大脑中会积累足够的β淀粉样蛋白(Aβ)以及神经原纤维缠结(NFT),从而在神经病理学上被诊断为AD,APP基因的三体化被认为是主要原因。关于DS患者中年龄与性别差异以及对痴呆症影响的研究结果并不一致。然而,与非DS女性相比,DS女性绝经年龄更早,其特征是雌激素水平下降。本综述重点关注DS患者中随年龄增长观察到的关键性别差异,以及对可能驱动或预防DS患者AD发展的潜在机制的讨论。了解生物性别如何影响大脑将有助于开发专门的治疗方法和干预措施,以提高DS和AD患者的生活质量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc8b/9411995/dee23a3a823c/fnins-16-954999-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc8b/9411995/dee23a3a823c/fnins-16-954999-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc8b/9411995/dee23a3a823c/fnins-16-954999-g0001.jpg

相似文献

1
Exploring the role of sex differences in Alzheimer's disease pathogenesis in Down syndrome.探索性别差异在唐氏综合征阿尔茨海默病发病机制中的作用。
Front Neurosci. 2022 Aug 12;16:954999. doi: 10.3389/fnins.2022.954999. eCollection 2022.
2
Rodent Modeling of Alzheimer's Disease in Down Syndrome: and Approaches.唐氏综合征中阿尔茨海默病的啮齿动物模型及方法
Front Neurosci. 2022 Jun 7;16:909669. doi: 10.3389/fnins.2022.909669. eCollection 2022.
3
Down Syndrome, Partial Trisomy 21, and Absence of Alzheimer's Disease: The Role of APP.唐氏综合征、21号染色体部分三体与阿尔茨海默病的缺失:淀粉样前体蛋白(APP)的作用
J Alzheimers Dis. 2017;56(2):459-470. doi: 10.3233/JAD-160836.
4
Aβ and tau prions feature in the neuropathogenesis of Down syndrome.β淀粉样蛋白和tau 朊病毒存在于唐氏综合征的神经发病机制中。
Proc Natl Acad Sci U S A. 2022 Nov 16;119(46):e2212954119. doi: 10.1073/pnas.2212954119. Epub 2022 Nov 7.
5
From understanding to action: Exploring molecular connections of Down syndrome to Alzheimer's disease for targeted therapeutic approach.从理解到行动:探索唐氏综合征与阿尔茨海默病的分子联系以制定靶向治疗方法。
Alzheimers Dement (Amst). 2024 Apr 14;16(2):e12580. doi: 10.1002/dad2.12580. eCollection 2024 Apr-Jun.
6
Characterization of monomeric and soluble aggregated Aβ in Down's syndrome and Alzheimer's disease brains.鉴定唐氏综合征和阿尔茨海默病患者脑中单体和可溶聚集态 Aβ。
Neurosci Lett. 2021 May 29;754:135894. doi: 10.1016/j.neulet.2021.135894. Epub 2021 Apr 10.
7
Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer's disease.唐氏综合征和散发性阿尔茨海默病中的淀粉样蛋白、tau 和细胞因子的血浆生物标志物。
Alzheimers Res Ther. 2019 Mar 21;11(1):26. doi: 10.1186/s13195-019-0477-0.
8
Neuroimaging and other modalities to assess Alzheimer's disease in Down syndrome.神经影像学及其他方法评估唐氏综合征患者的阿尔茨海默病。
Neuroimage Clin. 2017 Nov 6;17:263-271. doi: 10.1016/j.nicl.2017.10.022. eCollection 2018.
9
Impact of increased APP gene dose in Down syndrome and the Dp16 mouse model.唐氏综合征中 APP 基因剂量增加的影响及 Dp16 小鼠模型。
Alzheimers Dement. 2022 Jun;18(6):1203-1234. doi: 10.1002/alz.12463. Epub 2021 Nov 10.
10
Alzheimer's disease.阿尔茨海默病
Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14.

引用本文的文献

1
Age and sex are associated with Alzheimer's disease neuropathology in Down syndrome.年龄和性别与唐氏综合征中的阿尔茨海默病神经病理学相关。
Alzheimers Dement. 2025 Jul;21(7):e70408. doi: 10.1002/alz.70408.
2
Single-nucleus analysis reveals oxidative stress in Down syndrome basal forebrain neurons at birth.单核分析揭示唐氏综合征基底前脑神经元在出生时存在氧化应激。
Alzheimers Dement. 2025 Jul;21(7):e70445. doi: 10.1002/alz.70445.
3
Validation of the CAMCOG-DS-II, a neuropsychological test battery for Alzheimer's disease in people with Down syndrome: A Horizon 21 European Down syndrome Consortium study.

本文引用的文献

1
Alzheimer's disease associated with Down syndrome: a genetic form of dementia.唐氏综合征相关的阿尔茨海默病:一种遗传性痴呆。
Lancet Neurol. 2021 Nov;20(11):930-942. doi: 10.1016/S1474-4422(21)00245-3.
2
Synaptophysin-dependent synaptobrevin-2 trafficking at the presynapse-Mechanism and function.突触小泡蛋白依赖性突触融合蛋白 2 在突触前的运输:机制与功能。
J Neurochem. 2021 Oct;159(1):78-89. doi: 10.1111/jnc.15499. Epub 2021 Sep 9.
3
Diagnostic and prognostic performance and longitudinal changes in plasma neurofilament light chain concentrations in adults with Down syndrome: a cohort study.
用于唐氏综合征患者的阿尔茨海默病神经心理测试组合CAMCOG-DS-II的验证:地平线21欧洲唐氏综合征联盟研究
Alzheimers Dement. 2025 Mar;21(3):e70071. doi: 10.1002/alz.70071.
4
Calcineurin inhibition may prevent Alzheimer disease in people with Down syndrome.抑制钙调神经磷酸酶可能预防唐氏综合征患者患阿尔茨海默病。
Alzheimers Dement. 2025 Mar;21(3):e70034. doi: 10.1002/alz.70034.
5
Single-nucleus analysis reveals dysregulated oxidative phosphorylation in Down syndrome basal forebrain at birth.单核分析揭示唐氏综合征出生时基底前脑氧化磷酸化失调。
bioRxiv. 2025 Feb 6:2025.02.05.636750. doi: 10.1101/2025.02.05.636750.
6
Blood biomarkers in Down syndrome: Facilitating Alzheimer's disease detection and monitoring.唐氏综合征中的血液生物标志物:助力阿尔茨海默病的检测与监测。
Alzheimers Dement. 2025 Jan;21(1):e14364. doi: 10.1002/alz.14364. Epub 2024 Nov 13.
7
What Can We Learn About Alzheimer's Disease from People with Down Syndrome?从唐氏综合征患者身上我们能了解到哪些关于阿尔茨海默病的信息?
Curr Top Behav Neurosci. 2025;69:197-226. doi: 10.1007/7854_2024_546.
8
Neurobehavioral dysfunction in a mouse model of Down syndrome: upregulation of cystathionine β-synthase, HS overproduction, altered protein persulfidation, synaptic dysfunction, endoplasmic reticulum stress, and autophagy.唐氏综合征小鼠模型中的神经行为功能障碍:胱硫醚β-合酶上调、HS 过度产生、蛋白质过硫化改变、突触功能障碍、内质网应激和自噬。
Geroscience. 2024 Oct;46(5):4275-4314. doi: 10.1007/s11357-024-01146-8. Epub 2024 Apr 1.
9
Investigating brain alterations in the Dp1Tyb mouse model of Down syndrome.研究唐氏综合征Dp1Tyb小鼠模型中的脑部改变。
Neurobiol Dis. 2023 Nov;188:106336. doi: 10.1016/j.nbd.2023.106336.
10
Down Syndrome Biobank Consortium: A perspective.唐氏综合征生物样本库联盟:一个视角。
Alzheimers Dement. 2024 Mar;20(3):2262-2272. doi: 10.1002/alz.13692. Epub 2024 Jan 25.
唐氏综合征成人血浆神经丝轻链浓度的诊断和预后性能及纵向变化:一项队列研究。
Lancet Neurol. 2021 Aug;20(8):605-614. doi: 10.1016/S1474-4422(21)00129-0.
4
The Association between Sex and Risk of Alzheimer's Disease in Adults with Down Syndrome.唐氏综合征成年人的性别与阿尔茨海默病风险之间的关联。
J Clin Med. 2021 Jul 1;10(13):2966. doi: 10.3390/jcm10132966.
5
Alternative splicing in aging and Alzheimer's disease: Highlighting the role of tau and estrogen receptor α isoforms in the hypothalamus.衰老与阿尔茨海默病中的可变剪接:突显tau蛋白和雌激素受体α亚型在下丘脑中的作用
Handb Clin Neurol. 2021;182:177-189. doi: 10.1016/B978-0-12-819973-2.00012-5.
6
Association of Apolipoprotein E ɛ4 Allele With Clinical and Multimodal Biomarker Changes of Alzheimer Disease in Adults With Down Syndrome.载脂蛋白 E ɛ4 等位基因与唐氏综合征成人阿尔茨海默病的临床和多模态生物标志物变化的关联。
JAMA Neurol. 2021 Aug 1;78(8):937-947. doi: 10.1001/jamaneurol.2021.1893.
7
Neurofibrillary tau depositions emerge with subthreshold cerebral beta-amyloidosis in down syndrome.唐氏综合征患者出现亚临床大脑β淀粉样蛋白病变时会出现神经原纤维缠结。
Neuroimage Clin. 2021;31:102740. doi: 10.1016/j.nicl.2021.102740. Epub 2021 Jun 24.
8
The Behavioral and Psychological Symptoms of Dementia in Down Syndrome Scale (BPSD-DS II): Optimization and Further Validation.唐氏综合征患者的行为和心理症状量表(BPSD-DS II):优化和进一步验证。
J Alzheimers Dis. 2021;81(4):1505-1527. doi: 10.3233/JAD-201427.
9
Increase of blood-brain barrier leakage is related to cognitive decline in vascular mild cognitive impairment.血脑屏障通透性增加与血管性轻度认知障碍的认知能力下降有关。
BMC Neurol. 2021 Apr 15;21(1):159. doi: 10.1186/s12883-021-02189-6.
10
Astrocyte-immune cell interactions in physiology and pathology.星形胶质细胞-免疫细胞相互作用的生理和病理。
Immunity. 2021 Feb 9;54(2):211-224. doi: 10.1016/j.immuni.2021.01.013.